| Financial Year |
March 31 2023 |
| Monetary Funds |
55,087,198.09 |
| Held-for-trading Financial Assets |
233,220,000.00 |
| Notes Receivable |
8,602,662.74 |
| Accounts Receivable |
127,217,429.47 |
| Advances to Suppliers |
7,229,267.67 |
| Other Receivables |
735,688.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
196,381,488.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
240,342.87 |
| Total Current Assets |
658,089,059.24 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
268,645,764.17 |
| Under-construction Projects |
4,343,380.46 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
31,690,834.83 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
4,441,431.82 |
| Other Non-Current Assets |
15,632,047.59 |
| Sub-Total of Non-Current Assets |
324,906,339.95 |
| Total Assets |
982,995,399.19 |
| Short-Term Loans |
80,073,333.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
17,915,051.70 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,085,160.79 |
| Taxes Payable |
5,905,065.63 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,100,679.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
148,835.46 |
| Other Current Liabilities |
592,115.20 |
| Sub-Total of Current Liabilities |
119,194,883.11 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
328,547.79 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
8,411,469.37 |
| Total Liabilities |
127,606,352.48 |
| Paid-In Capital(Or Share Stock) |
165,900,000.00 |
| Capital Surplus |
288,423,025.94 |
| Surplus Reserve |
61,949,064.94 |
| LESS:Treasury Stock |
3,384,000.00 |
| Undistributed Profits |
342,500,955.83 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
855,389,046.71 |
| Owner's Equity（Stockholder's Equity） |
855,389,046.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
982,995,399.19 |
